Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium

Mitchell J. MacHiela, Sara Lindström, Naomi E. Allen, Christopher A. Haiman, Demetrius Albanes, Aurelio Barricarte, Sonja I. Berndt, H. Bas Bueno-De-Mesquita, Stephen Chanock, J. Michael Gaziano, Susan M. Gapstur, Edward Giovannucci, Brian E. Henderson, Eric J. Jacobs, Laurence N. Kolonel, Vittorio Krogh, Jing Ma, Meir J. Stampfer, Victoria L. Stevens, Daniel O. Stram & 6 others Anne Tjønneland, Ruth Travis, Walter C. Willett, David J. Hunter, Loic Le Marchand, Peter Kraft

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Observational studies have found an inverse association between type 2 diabetes (T2D) and prostate cancer (PCa), and genome-wide association studies have found common variants near 3 loci associated with both diseases. The authors examined whether a genetic background that favors T2D is associated with risk of advanced PCa. Data from the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium, a genome-wide association study of 2,782 advanced PCa cases and 4,458 controls, were used to evaluate whether individual single nucleotide polymorphisms or aggregations of these 36 T2D susceptibility loci are associated with PCa. Ten T2D markers near 9 loci (NOTCH2, ADCY5, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, MTNR1B, FTO, and HNF1B) were nominally associated with PCa (P <0.05); the association for single nucleotide polymorphism rs757210 at the HNF1B locus was significant when multiple comparisons were accounted for (adjusted P = 0.001). Genetic risk scores weighted by the T2D log odds ratio and multilocus kernel tests also indicated a significant relation between T2D variants and PCa risk. A mediation analysis of 9,065 PCa cases and 9,526 controls failed to produce evidence that diabetes mediates the association of the HNF1B locus with PCa risk. These data suggest a shared genetic component between T2D and PCa and add to the evidence for an interrelation between these diseases.

Original languageEnglish
Pages (from-to)1121-1129
Number of pages9
JournalAmerican Journal of Epidemiology
Volume176
Issue number12
DOIs
Publication statusPublished - Dec 15 2012

Fingerprint

Type 2 Diabetes Mellitus
Prostatic Neoplasms
Breast Neoplasms
Genome-Wide Association Study
Single Nucleotide Polymorphism
National Cancer Institute (U.S.)
Observational Studies
Odds Ratio

Keywords

  • carcinoma
  • diabetes mellitus, type 2
  • genetic predisposition to disease
  • genetics
  • genome-wide association study
  • humans
  • polymorphism, single nucleotide
  • prostatic neoplasms

ASJC Scopus subject areas

  • Epidemiology

Cite this

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium. / MacHiela, Mitchell J.; Lindström, Sara; Allen, Naomi E.; Haiman, Christopher A.; Albanes, Demetrius; Barricarte, Aurelio; Berndt, Sonja I.; Bas Bueno-De-Mesquita, H.; Chanock, Stephen; Michael Gaziano, J.; Gapstur, Susan M.; Giovannucci, Edward; Henderson, Brian E.; Jacobs, Eric J.; Kolonel, Laurence N.; Krogh, Vittorio; Ma, Jing; Stampfer, Meir J.; Stevens, Victoria L.; Stram, Daniel O.; Tjønneland, Anne; Travis, Ruth; Willett, Walter C.; Hunter, David J.; Le Marchand, Loic; Kraft, Peter.

In: American Journal of Epidemiology, Vol. 176, No. 12, 15.12.2012, p. 1121-1129.

Research output: Contribution to journalArticle

MacHiela, MJ, Lindström, S, Allen, NE, Haiman, CA, Albanes, D, Barricarte, A, Berndt, SI, Bas Bueno-De-Mesquita, H, Chanock, S, Michael Gaziano, J, Gapstur, SM, Giovannucci, E, Henderson, BE, Jacobs, EJ, Kolonel, LN, Krogh, V, Ma, J, Stampfer, MJ, Stevens, VL, Stram, DO, Tjønneland, A, Travis, R, Willett, WC, Hunter, DJ, Le Marchand, L & Kraft, P 2012, 'Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium', American Journal of Epidemiology, vol. 176, no. 12, pp. 1121-1129. https://doi.org/10.1093/aje/kws191
MacHiela, Mitchell J. ; Lindström, Sara ; Allen, Naomi E. ; Haiman, Christopher A. ; Albanes, Demetrius ; Barricarte, Aurelio ; Berndt, Sonja I. ; Bas Bueno-De-Mesquita, H. ; Chanock, Stephen ; Michael Gaziano, J. ; Gapstur, Susan M. ; Giovannucci, Edward ; Henderson, Brian E. ; Jacobs, Eric J. ; Kolonel, Laurence N. ; Krogh, Vittorio ; Ma, Jing ; Stampfer, Meir J. ; Stevens, Victoria L. ; Stram, Daniel O. ; Tjønneland, Anne ; Travis, Ruth ; Willett, Walter C. ; Hunter, David J. ; Le Marchand, Loic ; Kraft, Peter. / Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium. In: American Journal of Epidemiology. 2012 ; Vol. 176, No. 12. pp. 1121-1129.
@article{17939da7df7c422da2362d5fb7e0f47c,
title = "Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium",
abstract = "Observational studies have found an inverse association between type 2 diabetes (T2D) and prostate cancer (PCa), and genome-wide association studies have found common variants near 3 loci associated with both diseases. The authors examined whether a genetic background that favors T2D is associated with risk of advanced PCa. Data from the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium, a genome-wide association study of 2,782 advanced PCa cases and 4,458 controls, were used to evaluate whether individual single nucleotide polymorphisms or aggregations of these 36 T2D susceptibility loci are associated with PCa. Ten T2D markers near 9 loci (NOTCH2, ADCY5, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, MTNR1B, FTO, and HNF1B) were nominally associated with PCa (P <0.05); the association for single nucleotide polymorphism rs757210 at the HNF1B locus was significant when multiple comparisons were accounted for (adjusted P = 0.001). Genetic risk scores weighted by the T2D log odds ratio and multilocus kernel tests also indicated a significant relation between T2D variants and PCa risk. A mediation analysis of 9,065 PCa cases and 9,526 controls failed to produce evidence that diabetes mediates the association of the HNF1B locus with PCa risk. These data suggest a shared genetic component between T2D and PCa and add to the evidence for an interrelation between these diseases.",
keywords = "carcinoma, diabetes mellitus, type 2, genetic predisposition to disease, genetics, genome-wide association study, humans, polymorphism, single nucleotide, prostatic neoplasms",
author = "MacHiela, {Mitchell J.} and Sara Lindstr{\"o}m and Allen, {Naomi E.} and Haiman, {Christopher A.} and Demetrius Albanes and Aurelio Barricarte and Berndt, {Sonja I.} and {Bas Bueno-De-Mesquita}, H. and Stephen Chanock and {Michael Gaziano}, J. and Gapstur, {Susan M.} and Edward Giovannucci and Henderson, {Brian E.} and Jacobs, {Eric J.} and Kolonel, {Laurence N.} and Vittorio Krogh and Jing Ma and Stampfer, {Meir J.} and Stevens, {Victoria L.} and Stram, {Daniel O.} and Anne Tj{\o}nneland and Ruth Travis and Willett, {Walter C.} and Hunter, {David J.} and {Le Marchand}, Loic and Peter Kraft",
year = "2012",
month = "12",
day = "15",
doi = "10.1093/aje/kws191",
language = "English",
volume = "176",
pages = "1121--1129",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the breast and prostate cancer cohort consortium

AU - MacHiela, Mitchell J.

AU - Lindström, Sara

AU - Allen, Naomi E.

AU - Haiman, Christopher A.

AU - Albanes, Demetrius

AU - Barricarte, Aurelio

AU - Berndt, Sonja I.

AU - Bas Bueno-De-Mesquita, H.

AU - Chanock, Stephen

AU - Michael Gaziano, J.

AU - Gapstur, Susan M.

AU - Giovannucci, Edward

AU - Henderson, Brian E.

AU - Jacobs, Eric J.

AU - Kolonel, Laurence N.

AU - Krogh, Vittorio

AU - Ma, Jing

AU - Stampfer, Meir J.

AU - Stevens, Victoria L.

AU - Stram, Daniel O.

AU - Tjønneland, Anne

AU - Travis, Ruth

AU - Willett, Walter C.

AU - Hunter, David J.

AU - Le Marchand, Loic

AU - Kraft, Peter

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Observational studies have found an inverse association between type 2 diabetes (T2D) and prostate cancer (PCa), and genome-wide association studies have found common variants near 3 loci associated with both diseases. The authors examined whether a genetic background that favors T2D is associated with risk of advanced PCa. Data from the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium, a genome-wide association study of 2,782 advanced PCa cases and 4,458 controls, were used to evaluate whether individual single nucleotide polymorphisms or aggregations of these 36 T2D susceptibility loci are associated with PCa. Ten T2D markers near 9 loci (NOTCH2, ADCY5, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, MTNR1B, FTO, and HNF1B) were nominally associated with PCa (P <0.05); the association for single nucleotide polymorphism rs757210 at the HNF1B locus was significant when multiple comparisons were accounted for (adjusted P = 0.001). Genetic risk scores weighted by the T2D log odds ratio and multilocus kernel tests also indicated a significant relation between T2D variants and PCa risk. A mediation analysis of 9,065 PCa cases and 9,526 controls failed to produce evidence that diabetes mediates the association of the HNF1B locus with PCa risk. These data suggest a shared genetic component between T2D and PCa and add to the evidence for an interrelation between these diseases.

AB - Observational studies have found an inverse association between type 2 diabetes (T2D) and prostate cancer (PCa), and genome-wide association studies have found common variants near 3 loci associated with both diseases. The authors examined whether a genetic background that favors T2D is associated with risk of advanced PCa. Data from the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium, a genome-wide association study of 2,782 advanced PCa cases and 4,458 controls, were used to evaluate whether individual single nucleotide polymorphisms or aggregations of these 36 T2D susceptibility loci are associated with PCa. Ten T2D markers near 9 loci (NOTCH2, ADCY5, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, MTNR1B, FTO, and HNF1B) were nominally associated with PCa (P <0.05); the association for single nucleotide polymorphism rs757210 at the HNF1B locus was significant when multiple comparisons were accounted for (adjusted P = 0.001). Genetic risk scores weighted by the T2D log odds ratio and multilocus kernel tests also indicated a significant relation between T2D variants and PCa risk. A mediation analysis of 9,065 PCa cases and 9,526 controls failed to produce evidence that diabetes mediates the association of the HNF1B locus with PCa risk. These data suggest a shared genetic component between T2D and PCa and add to the evidence for an interrelation between these diseases.

KW - carcinoma

KW - diabetes mellitus, type 2

KW - genetic predisposition to disease

KW - genetics

KW - genome-wide association study

KW - humans

KW - polymorphism, single nucleotide

KW - prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84871216134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871216134&partnerID=8YFLogxK

U2 - 10.1093/aje/kws191

DO - 10.1093/aje/kws191

M3 - Article

VL - 176

SP - 1121

EP - 1129

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 12

ER -